Gsk Plc

Holdings as of Sep 30, 2026 · filed Nov 5, 2026

$497014970
Portfolio value
13
Positions
Source: SEC 13-F ↗
Original filing
# Holding Value % Port. Δ Shares Change (QoQ)
1 Crispr Therapeutics Ag $144297739 29.03% -612208 -19.01%
2 Vir Biotechnology Inc $95599666 19.23% — Held
3 Wave Life Sciences Inc $67509057 13.58% — NEW BUY
4 Biontech Se $65716106 13.22% -221298 -24.87%
5 Ideaya Biosciences Inc $51226654 10.31% — Held
6 Cytokinetics Inc $22438005 4.51% — Held
7 Lyell Immunopharma Inc $14808932 2.98% — Held
8 Spero Therapeutics Inc $11120633 2.24% — Held
9 Nkarta Inc $8254918 1.66% — Held
10 Fulcrum Therapeutics Inc $6607142 1.33% — Held
11 Bicycle Therapeutics Plc $5628784 1.13% — Held
12 Regenxbio Inc $2044064 0.41% — Held
13 Cvrx Inc $1763270 0.35% — Held

Closed last quarter

Wave Life Sciences Ltd

Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.